By Adam Tetz, Director of Worldwide Marketing, Peli BioThermal
At this time last year, the world was eagerly anticipating 2021. COVID-19 vaccines delivered hope for normalcy, and excitement grew over convenience-related changes to healthcare, work and more. But the pandemic had other plans. New COVID-19 variants emerged, supply chain issues deepened, and much of the day-to-day still looks different than pre-pandemic.
The cold chain industry experienced rapid growth in 2020 and continues to experience both growth and change for the foreseeable future. The pandemic’s influence remains, which creates opportunities to innovate and better serve pharmaceutical and healthcare customers delivering medicine in new ways. This sets the stage for a few of our predictions this year.
While COVID-19’s influence persists, we also see renewed interest in sustainability and the evolving impact of Brexit’s export regulations in the United Kingdom (UK). These will also shape how the pharmaceutical and cold chain industries operate. Let’s take a look at what all of this means for 2022.